Items where contributor is "Miserez, Andre Roger"
2013Hatz, F. and Benz, N. and Hardmeier, M. and Zimmermann, R. and Rueegg, S. and Schindler, C. and Miserez, A. R. and Gschwandtner, U. and Monsch, A. U. and Fuhr, P.. (2013) Quantitative EEG and apolipoprotein E-genotype improve classification of patients with suspected Alzheimer's disease. Clinical Neurophysiology, 124 (11). pp. 2146-2152. 2011Spiegel, René and Berres, Manfred and Miserez, André R. and Monsch, Andreas U. and Alzheimer's Disease Neuroimaging Initiative, . (2011) For debate: substituting placebo controls in long-term Alzheimer's prevention trials. Alzheimer's Research & Therapy, 3 (2). p. 9. 2009Sivasankaran, B. and Degen, M. and Ghaffari, A. and Hegi, M. E. and Hamou, M. F. and Ionescu, M. C. and Zweifel, C. and Tolnay, M. and Wasner, M. and Mergenthaler, S. and Miserez, A. R. and Kiss, R. and Lino, M. M. and Merlo, A. and Chiquet-Ehrismann, R. and Boulay, J. L.. (2009) Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. Cancer research : a journal of the American Association for Cancer Research, Vol. 69. pp. 458-465. 2008Taylor, Kirsten I. and Probst, Alphonse and Miserez, André R. and Monsch, Andreas U. and Tolnay, Markus. (2008) Clinical course of neuropathologically confirmed frontal-variant Alzheimer's disease. Nature clinical practice. Neurology, Vol. 4, no. 4. pp. 226-232. |